MedPath

Ketone Supplementation and Exercise Performance

Not Applicable
Conditions
Ketosis
Exercise Performance
Ketoses, Metabolic
Registration Number
NCT03954665
Lead Sponsor
Western University, Canada
Brief Summary

The purpose of this study is to observe the effects of exogenous ketone supplements during shorter bouts of exercise testing on twenty collegiate endurance trained athletes (18-25 years of age).

Detailed Description

Some believe very high fat diets (\>70% energy) can enhance exercise performance by providing additional fuel (ketones) for energy metabolism, at least for very prolonged exercise (\>3-4h). Regardless, this diet is difficult to maintain so it has been suggested that ingesting ketone salts along with a normal carbohydrate (CHO) diet might be more practical. The purpose of this study is to observe the effects of ketone salt ingestion on shorter term (up to \~15 min) exercise performance. Endurance trained (≥2 year training experience; ≥7 h/week) collegiate athletes (n=20) of similar body mass (♀; 55-60kg; ♂; 75-80kg) and age 18-25y) consuming 5-6g CHO•kg-1•d-1) will be tested before and after 1 and 7d of ketone salt (Prüvit, Carrollton TX, US) supplementation (0.6-0.8g•kg-1•d-1). Participants will perform two exercise performance tests (a 10km cycle time trial and a 30s Wingate cycle test on separate days) before and after supplementation. Blood samples (glucose, lactic acid, and ketone concentration) will be taken at: baseline and following each performance test. It is hypothesized that ketone salt supplementation will increase blood ketone concentration but will not enhance these exercise performance tests.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Healthy male or female Collegiate Endurance Trained Athletes
  • ≥2 year training experience; ≥7 h/week
  • Ages 18-25
Exclusion Criteria
  • Smoker
  • Injury that will affect exercise performance
  • Sedentary Behaviour
  • Currently following a High Fat diet/Ketogenic diet
  • Taking Beta Blockers or Hypertension Medication
  • Has Respiratory, Cardiovascular and/or Neuromuscular disease that is not cleared for exercise by a physician.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
10 km Time trial15-20 Minutes

10km time trial where participants will be measured on time to completion

30s Wingate30 seconds

30s Wingate all out test where participants will be measured on their peak power output

Secondary Outcome Measures
NameTimeMethod
Blood Glucose1-2 hours

Blood Glucose will be measured using a Blood glucose meter

Blood Lactate1-2 hours

Blood Lactate will be measured using a lactate meter

Blood Ketones1-2 hours

Blood Ketones will be measured using a ketone meter

Trial Locations

Locations (1)

Exercise Nutrition Laboratory, Western University

🇨🇦

London, Ontario, Canada

Exercise Nutrition Laboratory, Western University
🇨🇦London, Ontario, Canada
Peter WR Lemon, PhD
Contact
5196612111
plemon@uwo.ca

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.